Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Pathways of Eicosanoid Metabolism
NCT04464070Phase 1Enrolling by invitation
- Sponsor
- Vanderbilt University
- Start
- Aug 2020
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of prostaglandin d2 (4 arms), sponsored by Vanderbilt University. Primary endpoint: Prostaglandin metabolites. Started Aug 2020; status: enrolling by invitation.
02
Drugs
prostaglandin d2
Beyond the preview
Go deeper on NCT04464070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04464070.